MRL Home

Postgraduate study at the MRL

At any one time, around 20% of the researchers associated with the MRL are postgraduate students carrying out research towards a PhD degree. There is a balance between basic science and clinical students (clinical training fellows and MBPhD students).

***New***

4-year studentship available at the MRL

A studentship, funded by the BBSRC Doctoral Training Partnership, is available to start in October 2014, providing an excellent opportunity to study in an exciting interdisciplinary research environment and to develop skills in cutting-edge metabolic research

more information

 

PhD programmes - Basic Science

The MRL is the base for the inter-departmental, inter-disciplinary Wellcome Trust 4 year PhD programme in Metabolic and Cardiovascular Disease. This programme supports students undertaking interdisciplinary research at the forefront of international efforts to understand the interrelated problems of obesity, diabetes and cardiovascular disease.

Many PIs at the MRL have close links with additional PhD programmes, including:

PhD programme - Clinical Science

Aims of the Programme - it is essential that young clinicians with aptitude are able to receive high quality research training in clinical science - representing as they do the future of academic medicine. We can offer training in an outstanding environment in subjects that span the research spectrum from basic science to epidemiology and public health.

Other PhD and MPhil opportunities

Each year the MRL also accepts students for traditional 3-year PhD projects and for the 1-year MPhil by research, including both basic scientists and clinical trainees.

 

 

 

Students starting in Oct 2012

from left to right

Cheryl Brighton* (MBiochem, University of Bath)

Nikolay Milev* (BSc Biology and Biochemistry, University of Durham)

Joseph Polex-Wolf* (MPhil Bioscience Enterprise, University of Cambridge; M.S. Neuroscience, B.S. Neuroscience, B.S. Biology, Brandeis University)

Laura Schmidt (Molecular Life Sciences, Maastricht University)

He Jiang* (BEng Pharmaceutical Engineering, Shenyang Inst of Technology; MRes in Biomedical Sciences, University of Glasgow)

KimJee Goh (Biological Sciences, Nanyang Technological University Singapore)

Claudia-Gabriela Mitrofan* (MChem, University of East Anglia)

Sarah Leiter (MB PhD, university of Cambridge)

 

* Wellcome Trust 4-year PhD Programme

 

Our 4 year PhD Programme Students

Students starting Oct 2011 (from left to right)

Katie Skeffington (BA Physiology), Agnese Irkle (BSc Pharmacy, MSc Pharmacology), Peiran Yang (BA Pharmacology), Vivian Mullin (MSci Biochemistry), Naomi Penfold (BA Pharmacology), Emily Rowe (BSc Biochemistry)

 

Students starting October 2010 (from left-right)

Wei Yang (Clinical Medicine, Peking Union Medical College, China); Barbara Musial (Biochemistry, Jagiellonian University, Cracow, Poland); Luke Burke (Biomedical Sciences (Physiology), Edinburgh University, UK); Emma Robinson (Molecular and Cellular Biochemistry, Oxford University); Nenad Medic (Molecular Biology, University of Zagreb, Croatia); Constanze Hammerle (Medical and Pharmaceutical Biotechnology, IMC Krems University of Applied Sciences, Austria); Paul Richards (Pharmacy, Nottingham University, UK)

 

Students starting October 2009 (from left-right)

Alice Adriaenssens  (Biochemistry and Molecular Biology, UC Davis, USA ); Barbora Doslikova (Human Nutrition, Westminster University); Lynne Cairns (Biochemistry, Glasgow University); William Marsh (Biochemistry, Cardiff University); Maria Alfaradhi (Natural Sciences - Pharmacology, Cambridge University); Lindsey Berends (Physiology, Glasgow University); Ciara Lusby (Biochemistry, University College Dublin ).

 

Students starting October 2008 (from left-right)

Yue Zheng (Pharmacology, MPharmacol, Bath University); Matthew Ackers-Johnson (Natural Sciences - Biochemistry, MBiochem, Cambridge University); Chantal Heppolette (Natural Sciences - Pathology, BA, Cambridge University; Immunology, MSc, Imperial College London); Ana Vujic (Biomedical Laboratory Science, BSc, Jonkoping University; Medical Biology, MSc, Linkoping University); Crystal Mok (Pharmacy, MPharm, Nottingham

University); Iris Schmitt (Molecular Biology, Diplom, Ruprecht Karls University Heidelberg); Ucheora Obi (Human Sciences, BSc, University College London); Lee Siggens (Food and Human Nutrition, BSc, Newcastle University); Lucy Manico (Biological Sciences, BSc, Edinburgh University)